BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Halt Medical, Inc. 

101 E Vineyard Avenue
Suite 201
Livermore  California  94551  U.S.A.
Phone: 925-634-7943 Fax: n/a


SEARCH JOBS




Industry
Medical Device






 Company News
Halt Medical, Inc. Announces Aetna U.S. Healthcare And Coventry Health Care Positive Coverage Decision For The Acessa™ Procedure For Women With Symptomatic Fibroids 6/3/2014 9:37:02 AM
Halt Medical, Inc. Announces FDA Clearance Of The Acessa Guidance Hand Piece 5/12/2014 6:39:31 AM
Halt Medical, Inc. Secures $92.8 Million Ahead Of U.S. Launch Of Uterine Fibroid Treatment 4/3/2014 9:05:30 AM
Halt Medical, Inc. Release: New Data Show That Women With Uterine Fibroids Experienced Significant And Long-Term Improvement In Their Symptoms With The Acessa™ Procedure 11/12/2013 7:19:15 AM
Halt Medical, Inc. Announces That Brigham and Women's Faulkner Hospital is First New England Provider of the Acessa™ Procedure 8/21/2013 8:46:48 AM
Halt Medical, Inc. Release: the Fibroid Treatment Collaborative Adopts Acessa™ Procedure as First Line Surgical Therapy for Uterine Fibroids 7/25/2013 9:30:06 AM
Halt Medical, Inc. Announces New CPT® Code From the American Medical Association for RF Ablation of Uterine Fibroids 7/10/2013 9:06:08 AM
Halt Medical, Inc. Release: the Acessa™ System Wins Gold in the 15th Annual Medical Design Excellence Awards Competition 6/25/2013 10:18:02 AM
Halt Medical, Inc. Announces Initial Commercial Results; Expanded Launch of Acessa™ System 4/1/2013 9:40:02 AM
Halt Medical, Inc. Announces the First Commercial Use of the Acessa™ System 3/12/2013 10:02:30 AM
12